Swiss National Bank
PGEN icon

Swiss National Bank’s Precigen PGEN Stock Holding History

Swiss National Bank’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
390,600
+41,600
+12% +$180K ﹤0.01% 1894
2026
Q1 		$1.35M Hold
349,000
– – ﹤0.01% 2035
2025
Q4 		$1.46M Buy
+349,000
New +$1.35M ﹤0.01% 2010
2023
Q2 		– Sell
-325,000
Closed -$345K – 2643
2023
Q1 		$345K Buy
325,000
+81,300
+33% +$117K ﹤0.01% 2590
2022
Q4 		$370K Hold
243,700
– – ﹤0.01% 2624
2022
Q3 		$517K Hold
243,700
– – ﹤0.01% 2555
2022
Q2 		$327K Buy
243,700
+23,700
+11% +$35.2K ﹤0.01% 2705
2022
Q1 		$464K Buy
220,000
+14,700
+7% +$35.8K ﹤0.01% 2613
2021
Q4 		$762K Hold
205,300
– – ﹤0.01% 2564
2021
Q3 		$1.02M Buy
205,300
+4,200
+2% +$24.2K ﹤0.01% 2427
2021
Q2 		$1.31M Buy
201,100
+31,600
+19% +$221K ﹤0.01% 2342
2021
Q1 		$1.17M Buy
169,500
+14,500
+9% +$123K ﹤0.01% 2289
2020
Q4 		$1.58M Hold
155,000
– – ﹤0.01% 2044
2020
Q3 		$543K Buy
155,000
+9,900
+7% +$47K ﹤0.01% 2345
2020
Q2 		$724K Buy
145,100
+5,400
+4% +$18.4K ﹤0.01% 2270
2020
Q1 		$475K Hold
139,700
– – ﹤0.01% 2204
2019
Q4 		$764K Buy
139,700
+3,900
+3% +$22K ﹤0.01% 2275
2019
Q3 		$782K Buy
135,800
+20,900
+18% +$142K ﹤0.01% 2183
2019
Q2 		$879K Sell
114,900
-22,600
-16% -$122K ﹤0.01% 2182
2019
Q1 		$723K Buy
137,500
+4,300
+3% +$29.8K ﹤0.01% 2247
2018
Q4 		$871K Buy
133,200
+11,100
+9% +$124K ﹤0.01% 2081
2018
Q3 		$2.1M Hold
122,100
– – ﹤0.01% 1689
2018
Q2 		$1.7M Buy
122,100
+14,600
+14% +$247K ﹤0.01% 1805
2018
Q1 		$1.65M Hold
107,500
– – ﹤0.01% 1768
2017
Q4 		$1.24M Buy
107,500
+9,800
+10% +$146K ﹤0.01% 1957
2017
Q3 		$1.86M Hold
97,700
– – ﹤0.01% 1667
2017
Q2 		$2.35M Hold
97,700
– – ﹤0.01% 1482
2017
Q1 		$1.94M Buy
97,700
+1,240
+1% +$27.7K ﹤0.01% 1591
2016
Q4 		$2.32M Hold
96,460
– – ﹤0.01% 1455
2016
Q3 		$2.68M Buy
96,460
+807
+0.8% +$21.3K ﹤0.01% 1318
2016
Q2 		$2.33M Buy
95,653
+16,547
+21% +$469K ﹤0.01% 1393
2016
Q1 		$2.57M Buy
79,106
+16,043
+25% +$505K ﹤0.01% 1288
2015
Q4 		$1.88M Buy
63,063
+2,321
+4% +$78.2K ﹤0.01% 1385
2015
Q3 		$1.91M Buy
60,742
+8,980
+17% +$438K ﹤0.01% 1341
2015
Q2 		$2.5M Buy
51,762
+3,735
+8% +$157K 0.01% 1169
2015
Q1 		$2.08M Buy
48,027
+1,047
+2% +$37.6K 0.01% 1262
2014
Q4 		$1.24M Buy
46,980
+1,255
+3% +$27.5K ﹤0.01% 1605
2014
Q3 		$812K Hold
45,725
– – ﹤0.01% 1787
2014
Q2 		$1.1M Buy
45,725
+4,290
+10% +$87K ﹤0.01% 1674
2014
Q1 		$1.04M Buy
41,435
+8,789
+27% +$243K ﹤0.01% 1686
2013
Q4 		$743K Buy
+32,646
New +$660K ﹤0.01% 1743

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swiss National Bank's PGEN Position: Q2 2026 in Review

Swiss National Bank increased its Precigen (PGEN) stake by 12% in Q2 2026, buying an estimated $180K and bringing the position to 390,600 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

Swiss National Bank first reported a position in PGEN in Q4 2013 and has held it in 41 quarters since. The position peaked at $2.68M in Q3 2016. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Swiss National Bank held 390,600 shares of Precigen worth $2.23M as of Q2 2026.
  • Swiss National Bank bought 41,600 Precigen shares in Q2 2026, an estimated $180K.
  • Precigen made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1894 holding.
  • Swiss National Bank first reported a position in Precigen in Q4 2013 and has held it in 41 quarters since.
  • Swiss National Bank's Precigen position peaked at $2.68M in Q3 2016.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.